噬菌体治疗多重耐药ESKAPE菌感染的系统综述
该研究通过检索PubMed、Ovid、EMBASE和Cochrane Library数据库,从1102篇文章和摘要中筛选出30项研究,系统评价噬菌体治疗多重耐药ESKAPE病原体的临床研究。多数研究显示所用噬菌体有效(87%)且安全(67%),但仅少数研究检测了噬菌体耐药性(35%)。作者认为仍需临床研究和监管变革来确定噬菌体的安全性和有效性。
要点
- 多数研究报告噬菌体治疗有效(87%)且安全(67%),但证据有限。
- 仅35%的研究检测了噬菌体耐药性,耐药监测不足。
- 需更多临床研究与监管调整以推进噬菌体用于多重耐药菌感染。
核心结论
- 噬菌体治疗多重耐药ESKAPE感染在多数已发表研究中显示有效性和安全性,但证据尚不充分,需进一步临床研究与监管变革。
研究设计与样本
- 系统综述,检索PubMed、Ovid、EMBASE和Cochrane Library数据库。
- 从1102篇文章和摘要中,按选择性纳入标准、噬菌体标准和研究特征筛选并评价30项研究。
主要发现
- 多数研究显示所用噬菌体有效(87%)且安全(67%)。
- 少数研究检测了噬菌体耐药性(35%)。
关键数值与推荐
- 87%的研究显示噬菌体有效性。
- 67%的研究显示噬菌体安全性。
- 35%的研究检测了噬菌体耐药性。
临床怎么用
- 综述提出噬菌体选择的适当标准,并为临床医生和科学家提供成功治疗的建议。
局限性
- 噬菌体治疗多重耐药菌感染的临床研究较少,噬菌体耐药性检测不足,需更多临床研究与监管变革。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bacteriophages (phages) may constitute a natural, safe, and effective strategy to prevent and control multidrug-resistant organisms (MDROs), and ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens in particular. Few clinical studies have assessed the safety and efficacy of phages in patients infected with MDROs. This systematic review summarizes and critically evaluates published studies of phages in clinical practice and presents the appropriate phage selection criteria, as well as recommendations for clinicians and scientists for a successful therapy. Articles were identified through a search of the PubMed, Ovid, EMBASE, and Cochrane Library databases. Among 1102 articles and abstracts, 30 studies were selected and evaluated using selective inclusion criteria, phage criteria, and study characteristics. Most studies showed efficacy (87%) and safety (67%) of the tested phages, but few studies examined phage resistance (35%). Clinical studies and regulatory changes are needed to determine the safety and efficacy of phages and to advance their use in patients with MDRO infections.
引用
- El Haddad L, Harb CP, Gebara MA, et al. A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans. Clin Infect Dis. 2019. PMID: 30395179. doi:10.1093/cid/ciy947
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。